101 related articles for article (PubMed ID: 38713162)
1. Prostate cancer diagnosis rates among insured men with and without HIV in South Africa: a cohort study.
Ruffieux Y; Fernandez Villalobos NV; Didden C; Haas AD; Chinogurei C; Cornell M; Egger M; Maartens G; Folb N; Rohner E
Cancer Epidemiol Biomarkers Prev; 2024 May; ():. PubMed ID: 38713162
[TBL] [Abstract][Full Text] [Related]
2. Biochemical progression free and overall survival among Black men with stage IV prostate cancer in South Africa: Results from a prospective cohort study.
Pumpalova YS; Ramakrishnan A; May M; Pentz A; Minkowitz S; Doherty S; Singh E; Chen WC; Rebbeck TR; Neugut AI; Joffe M
Cancer Med; 2023 Dec; 13(1):. PubMed ID: 38158645
[TBL] [Abstract][Full Text] [Related]
3. Male circumcision for prevention of heterosexual acquisition of HIV in men.
Siegfried N; Muller M; Volmink J; Deeks J; Egger M; Low N; Weiss H; Walker S; Williamson P
Cochrane Database Syst Rev; 2003; (3):CD003362. PubMed ID: 12917962
[TBL] [Abstract][Full Text] [Related]
4. Racial differences in the treatment and outcomes for prostate cancer in Massachusetts.
Cole AP; Herzog P; Iyer HS; Marchese M; Mahal BA; Lipsitz SR; Nyambose J; Gershman ST; Kennedy M; Merriam G; Rebbeck TR; Trinh QD
Cancer; 2021 Aug; 127(15):2714-2723. PubMed ID: 33999405
[TBL] [Abstract][Full Text] [Related]
5. Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality.
Björnebo L; Nordström T; Discacciati A; Palsdottir T; Aly M; Grönberg H; Eklund M; Lantz A
JAMA Oncol; 2022 Jul; 8(7):1019-1026. PubMed ID: 35587340
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of multimorbidity in men of African descent with and without prostate cancer in Soweto, South Africa.
Mapanga W; Norris SA; Craig A; Pumpalova Y; Ayeni OA; Chen WC; Jacobson JS; Neugut AI; Muchengeti M; Pentz A; Doherty S; Minkowitz S; Haffejee M; Rebbeck T; Joffe M
PLoS One; 2022; 17(10):e0276050. PubMed ID: 36256648
[TBL] [Abstract][Full Text] [Related]
7. Cervical precancer and cancer incidence among insured women with and without HIV in South Africa.
Fernández Villalobos NV; Ruffieux Y; Haas AD; Chinogurei C; Cornell M; Taghavi K; Egger M; Folb N; Maartens G; Rohner E
Int J Cancer; 2024 Jan; 154(2):273-283. PubMed ID: 37658695
[TBL] [Abstract][Full Text] [Related]
8. An application of propensity score weighting to quantify the causal effect of rectal sexually transmitted infections on incident HIV among men who have sex with men.
Vaughan AS; Kelley CF; Luisi N; del Rio C; Sullivan PS; Rosenberg ES
BMC Med Res Methodol; 2015 Mar; 15():25. PubMed ID: 25888416
[TBL] [Abstract][Full Text] [Related]
9. Prostate carcinoma among men with human immunodeficiency virus infection.
Crum NF; Spencer CR; Amling CL
Cancer; 2004 Jul; 101(2):294-9. PubMed ID: 15241826
[TBL] [Abstract][Full Text] [Related]
10. Variations in Age-Adjusted Prostate Cancer Incidence Rates by Race and Ethnicity After Changes in Prostate-Specific Antigen Screening Recommendation.
Lai SM; Keighley J; Garimella S; Enko M; Parker WP
JAMA Netw Open; 2022 Nov; 5(11):e2240657. PubMed ID: 36342715
[TBL] [Abstract][Full Text] [Related]
11. Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.
Hamdy FC; Donovan JL; Lane JA; Mason M; Metcalfe C; Holding P; Wade J; Noble S; Garfield K; Young G; Davis M; Peters TJ; Turner EL; Martin RM; Oxley J; Robinson M; Staffurth J; Walsh E; Blazeby J; Bryant R; Bollina P; Catto J; Doble A; Doherty A; Gillatt D; Gnanapragasam V; Hughes O; Kockelbergh R; Kynaston H; Paul A; Paez E; Powell P; Prescott S; Rosario D; Rowe E; Neal D
Health Technol Assess; 2020 Aug; 24(37):1-176. PubMed ID: 32773013
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous melanoma, prostate-specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study.
Egger S; Smith DP; Patel MI; Kimlin MG; Armstrong BK; Nair-Shalliker V
Br J Cancer; 2023 Jan; 128(1):71-79. PubMed ID: 36319848
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men.
Marcus JL; Chao CR; Leyden WA; Xu L; Klein DB; Horberg MA; Towner WJ; Quesenberry CP; Abrams DI; Van Den Eeden SK; Silverberg MJ
J Acquir Immune Defic Syndr; 2014 Aug; 66(5):495-502. PubMed ID: 24820107
[TBL] [Abstract][Full Text] [Related]
14. Downstream tests, treatments, and annual direct payments in older men cared for by primary care providers with high or low prostate-specific antigen screening rates using 100 percent Texas U.S. Medicare public insurance claims data: a retrospective cohort study.
Zanwar P; Lin YL; Kuo YF; Goodwin JS
BMC Health Serv Res; 2016 Jan; 16():17. PubMed ID: 26772175
[TBL] [Abstract][Full Text] [Related]
15. Prostate Cancer Screening and Incidence among Aging Persons Living with HIV.
Leapman MS; Stone K; Wadia R; Park LS; Gibert CL; Goetz MB; Bedimo R; Rodriguez-Barradas M; Shebl F; Justice AC; Brown ST; Crothers K; Sigel KM
J Urol; 2022 Feb; 207(2):324-332. PubMed ID: 34555924
[TBL] [Abstract][Full Text] [Related]
16. Association between patient ethnicity and prostate cancer diagnosis following a prostate-specific antigen test: a cohort study of 730,000 men in primary care in the UK.
Down L; Barlow M; Bailey SER; Mounce LTA; Merriel SWD; Watson J; Martins T
BMC Med; 2024 Mar; 22(1):82. PubMed ID: 38424555
[TBL] [Abstract][Full Text] [Related]
17. Trends in HIV incidence between 2013-2019 and association of baseline factors with subsequent incident HIV among gay, bisexual, and other men who have sex with men attending sexual health clinics in England: A prospective cohort study.
Hanum N; Cambiano V; Sewell J; Rodger AJ; Nwokolo N; Asboe D; Gilson R; Clarke A; Miltz AR; Collins S; Delpech V; Croxford S; Phillips AN; Lampe FC;
PLoS Med; 2021 Jun; 18(6):e1003677. PubMed ID: 34143781
[TBL] [Abstract][Full Text] [Related]
18. Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability.
Cooperberg MR; Zheng Y; Faino AV; Newcomb LF; Zhu K; Cowan JE; Brooks JD; Dash A; Gleave ME; Martin F; Morgan TM; Nelson PS; Thompson IM; Wagner AA; Carroll PR; Lin DW
JAMA Oncol; 2020 Oct; 6(10):e203187. PubMed ID: 32852532
[TBL] [Abstract][Full Text] [Related]
19. Serum prostate-specific antigen levels in older men with or at risk of HIV infection.
Vianna LE; Lo Y; Klein RS
HIV Med; 2006 Oct; 7(7):471-6. PubMed ID: 16925734
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
